We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01352663
Recruitment Status : Unknown
Verified May 2014 by Wockhardt.
Recruitment status was:  Not yet recruiting
First Posted : May 12, 2011
Last Update Posted : May 29, 2014
Sponsor:
Information provided by (Responsible Party):
Wockhardt

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2016
  Estimated Study Completion Date : January 2017